Rosangela Lattanzio Selected Research

Type 1 Diabetes Mellitus (Autoimmune Diabetes)

7/2011

Macular micropseudocysts in early stages of diabetic retinopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rosangela Lattanzio Research Topics

Disease

22	Macular Edema 04/2024 - 01/2007
12	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2023 - 01/2007
10	Retinal Vein Occlusion 06/2023 - 01/2013
3	Type 2 Diabetes Mellitus (MODY) 04/2020 - 07/2011
2	Cataract (Cataracts) 03/2024 - 10/2020
2	Inflammation (Inflammations) 01/2021 - 12/2020
2	Macular Degeneration (Age-Related Maculopathy) 01/2017 - 01/2007
2	Ischemia 11/2014 - 05/2014
1	Rare Diseases (Rare Disease) 10/2022
1	Epiretinal Membrane (Epiretinal Membranes) 04/2022
1	Ocular Hypertension (Glaucoma, Suspect) 01/2021
1	Optic Disk Drusen (Optic Disc Drusen) 01/2020
1	Arteriovenous Malformations (Arteriovenous Malformation) 01/2020
1	Embolism (Embolus) 03/2017
1	Blindness (Hysterical Blindness) 03/2017
1	Glaucoma 01/2017
1	Choroidal Neovascularization 05/2015
1	Retinoschisis (Retinoschisis, Juvenile) 11/2014
1	Edema (Dropsy) 05/2014
1	Retinal Perforations 02/2013
1	Diabetes Mellitus 02/2013
1	Hypoxia (Hypoxemia) 09/2012
1	Cavernous Hemangioma (Cavernous Angioma) 01/2012
1	Neoplasms (Cancer) 01/2012
1	Telangiectasis (Telangiectasia) 01/2012
1	Capillary Hemangioma 01/2012
1	Microaneurysm 01/2012
1	Retinal Telangiectasis 01/2012
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2011
1	Disease Progression 01/2011
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2007
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2007

Drug/Important Bio-Agent (IBA)

16	Retinaldehyde (Retinal)IBA 04/2024 - 07/2011
9	Dexamethasone (Maxidex)FDA LinkGeneric 10/2020 - 01/2012
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2020 - 01/2007
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2012
4	Fluocinolone Acetonide (Capex)FDA LinkGeneric 02/2024 - 01/2020
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 01/2011
2	SteroidsIBA 01/2017 - 01/2014
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	Endothelial Growth FactorsIBA 01/2020
1	Neuroprotective AgentsIBA 01/2019
1	Brimonidine Tartrate (Alphagan)FDA LinkGeneric 01/2019
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2019
1	Ranibizumab (Lucentis)FDA Link 07/2015
1	Chromogranin AIBA 05/2015
1	vasostatin IIBA 05/2015
1	Fluorescein (Funduscein)FDA LinkGeneric 05/2014
1	SmokeIBA 05/2014
1	erucylphosphocholineIBA 04/2012

Therapy/Procedure

5	Therapeutics 03/2024 - 01/2012
3	Lasers (Laser) 01/2017 - 02/2013
1	Intravitreal Injections 01/2023
1	Vitrectomy 04/2022
1	Injections 01/2020
1	Topical Administration 01/2019
1	Cardiac Resynchronization Therapy Devices 03/2017
1	Cardiac Resynchronization Therapy 03/2017
1	Contraindications 01/2017
1	Retreatment 06/2015
1	Slit Lamp 05/2014
1	Vitreoretinal Surgery 02/2013
1	Light Coagulation 02/2013